Featured
Last news
How to Sell Your Business Online (2025 Guide Released)
Find out how to sell your business online quickly through IRAEmpire.com's recent published guide on the topic.
Unusual Machines, Inc. Announces Closing in which it Sold $40 Million in a Public Offering of Common Stock
ORLANDO, FLORIDA / ACCESS Newswire / May 7, 2025 / Unusual Machines, Inc. (the "Company"), a United States based manufacturer and distributor of drone parts has successfully closed a confidentially marketed public offering for the sale of 8,000,000 shares of the Company's Common Stock at the offering price of $5.00 per share (the "Offering") resulting in gross proceeds of $40 million, before deducting placement agent fees and other offering expenses. The Offering closed on May 7, 2025.
Xactly and ServiceNow Join Forces to Unify Sales Order Management & Sales Performance Management
Strategic collaboration to optimize revenue performance and sales order management
SideChannel Reports Second Quarter Results
Financial results conference call on Wednesday, May 7 @ 4:30 P.M. ET
Ondas Holdings to Report First Quarter 2025 Financial Results on May 15, 2025 at 8:30 a.m. ET
BOSTON, MASSACHUSETTS / ACCESS Newswire / May 7, 2025 / Ondas Holdings Inc. (Nasdaq:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions, will hold a conference call on Thursday, May 15, 2025, at 8:30 a.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2025. The results will be reported in a press release prior to the conference call.
Centaris Acquires Hi-Tech System Service, Inc. to Expand Regional Footprint and Capabilities
STERLING HEIGHTS, MI / ACCESS Newswire / May 7, 2025 / Centaris, a leading provider of managed IT and business technology solutions, today announced the acquisition of Hi-Tech System Service, Inc., a Casco, MI-based firm with a long-standing reputation for delivering trusted IT services to businesses, schools, and municipalities across the region.
National JanSan Distributor Launches HawkSearch to Power AI-Driven Product Discovery
Smart Search, Merchandising Tools, and Personalization Features Now Live
Uplift Aerospace & Salt Lake City School District Expand Starborn Academy with Astrolab and Dr. Sian Proctor to Launch Student Projects to the Moon
PARK CITY, UTAH / ACCESS Newswire / May 7, 2025 / Uplift Aerospace (OTC PINK:NRPI) is proud to announce the expansion of its Starborn Academy education program through a groundbreaking collaboration with Astrolab and astronaut Dr. Sian Proctor. This program-Moon Mission: Letter to the Moon-invites middle school students to write and code digital time capsules with the opportunity of launching to the lunar surface aboard Astrolab's FLIP rover. The FLIP rover will be delivered to the Moon by Astrobotic's Griffin Mission-1 lander, a commercial mission awarded through NASA's Commercial Lunar Payload Services (CLPS) initiative.
T-Mobile Czech Republic Completes Billing & Charging System Upgrade with Amdocs
Completion of this upgrade ensures seamless service continuity and operational efficiency, enhancing customer experience by enabling faster, more agile, and reliable service delivery
Singapore's M1 Collaborates with Amdocs to Manage Newly Delivered Cloud-Native Charging Platform
The agreement will foster growth, enhance operational efficiency, and empower M1 to deliver consistent, high-quality end-user experiences
eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST
MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Monday, May 12, 2025 at 5:00 PM Eastern Time to discuss its results for the first quarter of 2025, as well as share more details around the newly formed purpose-built subsidiary, NCTx.
Gad Offers No Plan for Future of Paragon
Paragon Has a Strategic Plan to Create Shareholder Value
Consumer Cellular Selects Amdocs connectX to Accelerate Launch of New Services
AI-powered connectX platform to enhance the U.S. wireless operator's growth initiatives, enabling rapid deployment and management of innovative offerings
PLDT Goes Live with the Amdocs Customer Engagement Platform to Redefine Customer Experiences
The cloud-native, AI-enabled Amdocs platform, in collaboration with Microsoft, modernizes PLDT's customer service, enabling faster service rollouts, end-to-end case management, and real-time network-to-service integration
A1 Bulgaria Successfully Completes Major Platform Upgrade with Amdocs to Improve Customer Experience
Convergent charging platform upgrade is the final stage in the Bulgarian operator's platform modernization program, providing end users with faster response times, greater billing transparency, and improved service reliability
Japan's NTT InfraNet Successfully Deploys Advanced, Cloud-Native Platform, and Migrates Workloads with Amdocs
By modernizing and migrating its IT operations systems to the cloud, NTT InfraNet will now be able to introduce innovative services across multiple divisions and support their business ambitions
CKH Innovations Opportunities Development Selects Amdocs MarketONE to Enhance its Telco Group's Digital Service Offerings
By addressing key challenges such as partner management, subscription fatigue, and customer retention, Amdocs MarketONE equips participating CK Hutchison telco companies to grow their digital ecosystem and capture new revenue streams, while delivering enhanced experiences to their customers
CSPi to Announce Fiscal Second Quarter Results on May 14, 2025
LOWELL, MA / ACCESS Newswire / May 7, 2025 / CSPi (NASDAQ:CSPI), an award-winning provider of security and packet capture products, managed IT and professional services and technology solutions, announced that it will issue its fiscal 2025 second quarter financial results before the open of the market on Wednesday May 14, 2025.
Amdocs Limited Reports Second Quarter Fiscal 2025 Results
Revenue of $1.13 Billion, down 9.4% YoY as Reported and up 4.0% YoY in Pro Forma(1) Constant Currency(2)
SpaceX gets US approval to launch more Starship flights from Texas
Elon Musk's SpaceX on Tuesday received approval from the US Federal Aviation Administration (FAA) to increase the number of annual Starship rocket launches from five to 25 at its Texas base, marking a major boost for the company's ambitions.
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order
ACCESS Newswire to Host First Quarter Earnings Conference Call on May 13, 2025
RALEIGH, NC / ACCESS Newswire / May 6, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced it will host a conference call and live webcast on May 13, 2025, at 9:00am Eastern Time to discuss the results of the first quarter 2025.
Movella Holdings Inc. Announces Completion of Corporate Restructuring
LOS ANGELES, CA / ACCESS Newswire / May 6, 2025 / Movella Holdings Inc. (the "Company") today announced the completion of a restructuring transaction involving its wholly-owned subsidiary, Movella Inc. ("Movella"), and its existing secured lenders.
Eden Radioisotopes and Cross River Infrastructure Partners Sign MOU to Explore Development of a New Generation Medical Radioisotope Reactor in New Brunswick
ALBUQUERQUE, NM AND GREENWICH, CT / ACCESS Newswire / May 6, 2025 / Eden Radioisotopes, LLC ("Eden") and Cross River Infrastructure Partners, LLC ("CRIP") are pleased to announce the execution of a Memorandum of Understanding (MOU) to jointly explore the development of a new nuclear medical radioisotope reactor and hot cell processing facility in the Province of New Brunswick, Canada. This collaboration marks a significant step forward in Canada's efforts to expand its capabilities in nuclear medicine and build a resilient, regionally anchored supply chain for lifesaving radiodiagnostics and radiopharmaceuticals to bolster regional and national healthcare sovereignty by enabling a secure and sustainable supply of critical medical radioisotopes.
Ryde Reaffirms Commitment to Gig Workers at NTUC May Day Rally, Supporting Inclusive Growth and Fair Work Practices
SINGAPORE, SINGAPORE / ACCESS Newswire / May 6, 2025 / Ryde Group Ltd (NYSE American:RYDE) ("Ryde'' or the "Company"), a technology company with a leading platform for mobility and quick commerce in Singapore, proudly reaffirmed its commitment to gig workers at the NTUC May Day Rally 2025, joining over 1,600 union leaders, tripartite partners, and fellow Singaporeans in support of a more inclusive, resilient workforce.
OMP Achieves Top Two Rankings in Four Use Cases in the 2025 Gartner Critical Capabilities for Supply Chain Planning Solutions Report
ANTWERPEN, BE / ACCESS Newswire / May 6, 2025 / OMP, a global leader in supply chain planning solutions, has achieved four second-highest scores across five Use Cases, evaluated in the 2025 Gartner® Critical Capabilities for Supply Chain Planning Solutions report. This report, a companion to the Gartner Magic Quadrant™, assesses the vendors of the SCP solutions evaluated in this research.
Netlist Reports First Quarter 2025 Results
IRVINE, CA / ACCESS Newswire / May 6, 2025 / Netlist, Inc. (OTCQB:NLST) today reported financial results for the first quarter ended March 29, 2025.
Thrive in 2025 by Tony Robbins and Dean Graziosi: What It Is, When It Happens, and Who It's For (Guide Released)
IRAEmpire.com has published a detailed review and update on the Thrive in 2025 event for consumers.
Upexi Increases Solana Treasury to 201,500 Solana Tokens for $30 Million and Begins to Generate Staking Revenue
Company has over $60 million in cash remaining to invest further in SOLAt current price of SOL and staking yield, Upexi expects to receive approximately $2.4 million in annual staking revenue and $7.0 million once all funds are invested and staked
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / May 6, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology released pharmacokinetic and metabolism data from its Phase 1 study of TH104, a buccal film formulation of nalmefene, in healthy subjects. Tharimmune recently highlighted the advancement of TH104 for the proposed indication of temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, following recent positive feedback from the U.S. Food and Drug Administration (FDA).
Greenlite Announces Pre-Launch of NLCSwap a Fully U.S. Compliant Decentralized DEX Crypto Exchange
LOS ANGELES, CALIFORNIA / ACCESS Newswire / May 6, 2025 / Greenlite Ventures, Inc. is proud to announce the pre-launch of NLCSwap.com starting in Montana, a revolutionary decentralized cryptocurrency exchange that combines the best of both worlds: the autonomy and security of a decentralized exchange (DEX) with full compliance under U.S. regulations, including FinCEN registration and strict adherence to KYC (Know Your Customer) and AML (Anti-Money Laundering) protocols.
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.eXoZymes used its AI-driven development platform to progress from idea to purpose-built subsidiary in less than 3 months and at a fraction of normal SynBio R&D cost.NCTx is scaling up an exozyme biosolution to overcome a longstanding bottleneck in sourcing the NCT compound from nature, where it occurs only in trace amounts.Interesting pre-clinical data point towards Non-Alcoholic Fatty Liver Disease (NAFLD) that affects more than 30% of the global population.Only NCTx can make both the natural product NCT, and a range of very interesting new-to-nature analog versions, expanding the pharma potential.NCT is the first of more "powered by eXoZymes" natural product nutraceuticals, that also have the potential to become pharmaceuticals.